HST Global Inc. EPS Growth (basic)

EPS Growth (basic) of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (basic) growth rates and interactive chart. Year over year growth in basic earnings per share.


Highlights and Quick Summary

  • EPS Growth (basic) for the quarter ending September 29, 2018 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (basic) decreased by NaN%
  • Annual EPS Growth (basic) for 2019 was 283.38% (a -2566.32% decrease from previous year)
  • Annual EPS Growth (basic) for 2018 was -11.49% (a -294.42% decrease from previous year)
  • Annual EPS Growth (basic) for 2017 was 5.91% (a -88.99% decrease from previous year)
  • Twelve month EPS Growth (basic) ending September 29, 2018 was 0.0% (a NaN% decrease compared to previous quarter)
  • Twelve month trailing EPS Growth (basic) decreased by NaN% year-over-year
Trailing EPS Growth (basic) for the last four month:
29 Sep '18 29 Jun '18 30 Mar '18 29 Sep '17
0.0% 0.0% 0.0% 0.0%
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (basic) of HST Global Inc.

Most recent EPS Growth (basic)of HSTC including historical data for past 10 years.

Interactive Chart of EPS Growth (basic) of HST Global Inc.

HST Global Inc. EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 283.38%
2018 0.0% 0.0% 0.0% -11.49%
2017 0.0% 0.0% 0.0% 5.91%
2016 0.0% 0.0% 0.0% 53.7%
2015 0.0% 0.0% 0.0% 0.0% 0.0%
2014 0.0% 0.0% 0.0% 0.0% 0.0%
2013 0.0% 0.0% 0.0% 0.0% 0.0%
2012 100.0% 0.0% 0.0% 0.0% 0.0%
2011 0.0% 100.0% 100.0% 100.0% 66.67%
2010 0.0% 0.0% 0.0% 0.0% 39.99%

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.